| Literature DB >> 29351295 |
Sophie L W Spoorenberg1, Klaske Wynia1,2, Ronald J Uittenbroek1, Hubertus P H Kremer2, Sijmen A Reijneveld1.
Abstract
OBJECTIVE: To evaluate the effects of the population-based, person-centred and integrated care service 'Embrace' at twelve months on three domains comprising health, wellbeing and self-management among community-living older people.Entities:
Mesh:
Year: 2018 PMID: 29351295 PMCID: PMC5774687 DOI: 10.1371/journal.pone.0190751
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primary and secondary measurement instruments per risk profile.
| Complex care needs | Frail | Robust | ||||
|---|---|---|---|---|---|---|
| Primary | Secondary | Primary | Secondary | Primary | Secondary | |
| Health | ||||||
| EQ-5D-3L | X | X | X | |||
| INTERMED-E-SA | X | X | X | |||
| GFI | X | X | X | |||
| Katz-15 | X | X | X | |||
| Wellbeing | ||||||
| GWI | X | X | X | |||
| QoL | X | X | X | |||
| Self-management | ||||||
| SMAS-30 | X | X | X | |||
| PIH-OA | X | X | X | |||
EQ-5D-3L = EuroQol-5D-3L including the EuroQol visual analogue scale; GFI: Groningen Frailty Indicator; GWI = Groningen Well-being Indicator; INTERMED-E-SA = INTERMED for the Elderly Self-Assessment; PIH-OA = Partners in Health scale for older adults; QoL = Quality of life; SMAS-30 = Self-Management Ability Scale version 2.
Fig 1CONSORT flow diagram of the Embrace study.
Baseline characteristics of participants (n = 1456).
Values are numbers (percentages) unless stated otherwise.
| Whole sample | Complex care needs | Frail | Robust | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 1456) | (n = 365) | (n = 237) | (n = 854) | |||||||||||||
| Embrace | CAU | Embrace | CAU | Embrace | CAU | Embrace | CAU | |||||||||
| (n = 747) | (n = 709) | (n = 187) | (n = 178) | (n = 122) | (n = 115) | (n = 438) | (n = 416) | |||||||||
| Age in years, mean (SD) | 80.6 | (4.5) | 80.8 | (4.7) | 81.8 | (4.6) | 81.5 | (4.9) | 81.6 | (5.1) | 82.8 | (5.5) | 79.9 | (4.0) | 79.9 | (4.1) |
| Female | 405 | (54.2) | 394 | (55.6) | 121 | (64.7) | 115 | (64.6) | 82 | (67.2) | 80 | (69.6) | 202 | (46.1) | 199 | (47.8) |
| Widowed/divorced/single | 320 | (42.8) | 290 | (41.0) | 87 | (46.5) | 79 | (44.4) | 77 | (63.1) | 72 | (63.2) | 156 | (35.6) | 139 | (33.5) |
| In sheltered accommodation/home for the elderly | 93 | (12.5) | 99 | (14.0) | 37 | (19.9) | 40 | (22.6) | 20 | (16.4) | 26 | (22.8) | 36 | (8.3) | 33 | (8.0) |
| Low educational level | 370 | (49.9) | 374 | (53.4) | 106 | (57.0) | 116 | (66.3) | 66 | (54.1) | 69 | (60.0) | 198 | (45.7) | 189 | (46.0) |
| Low income | 261 | (44.1) | 231 | (42.4) | 80 | (54.1) | 77 | (54.2) | 53 | (55.8) | 51 | (54.8) | 128 | (36.7) | 103 | (33.2) |
| Number of chronic conditions, median (IQR) | 2 | (1–3) | 2 | (1–3) | 3 | (2–5) | 3 | (2–5) | 3 | (1–4) | 3 | (2–4) | 1 | (1–2) | 1 | (1–2) |
| Receiving home care | 89 | (12.1) | 69 | (9.8) | 47 | (26.4) | 42 | (23.9) | 24 | (20.0) | 14 | (12.4) | 18 | (4.1) | 13 | (3.2) |
| Receiving help with filling in the questionnaire | 243 | (32.8) | 245 | (35.0) | 99 | (53.8) | 106 | (60.2) | 48 | (39.3) | 43 | (37.7) | 96 | (22.1) | 96 | (23.4) |
CAU = Care as usual; IQR = Interquartile range; SD = Standard deviation.
1 Low: (Less than) primary school or low vocational training.
2 Low: <€1350 per month.
Values are based on complete data. There were no significant differences between CAU and Embrace–neither for the whole sample nor per risk profile. This was tested using independent t-tests for continuous variables, Chi-square tests for categorical variables, and Mann-Whitney U tests for non-normally distributed continuous variables and ordinal variables.
Patient-reported outcomes at 12-month follow-up in the Embrace study: Overview of the results of the intention-to-treat multilevel analyses for the whole sample and per risk profile.
| Whole sample | Complex care needs | Frail | Robust | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 1456) | (n = 365) | (n = 237) | (n = 854) | |||||||||||||||
| Embrace | CAU | Embrace | CAU | Embrace | CAU | Embrace | CAU | |||||||||||
| Scale scores | Higher score | Mean change | Mean change | p-value | ES | Mean change | Mean change | p-value | ES | Mean change | Mean change | p-value | ES | Mean change | Mean change | p-value | ES | |
| EQ-5D-3L | -0.33–1.00 | + | 0.00 | 0.00 | 0.670 | 0.02 | -0.02 | -0.01 | 0.521 | 0.07 | -0.02 | 0.0 | 0.223 | 0.16 | 0.01 | 0.01 | 0.630 | 0.03 |
| EQ-VAS | 0–100 | + | -0.5 | -0.6 | 0.878 | 0.01 | -0.1 | 1.6 | 0.323 | 0.10 | -1.7 | -3.0 | 0.387 | 0.11 | -0.4 | -0.9 | 0.511 | 0.05 |
| INTERMED-E-SA | 0–60 | - | -0.1 | -0.2 | 0.597 | 0.03 | -1.9 | -2.6 | 0.149 | 0.15 | 1.4 | 1.3 | 0.608 | 0.06 | 0.3 | 0.5 | 0.540 | 0.04 |
| GFI | 0–15 | - | 0.1 | 0.1 | 0.998 | 0.00 | 0.1 | 0.0 | 0.552 | 0.06 | -0.6 | -0.7 | 0.586 | 0.07 | 0.4 | 0.5 | 0.411 | 0.06 |
| Katz-15 | 0–15 | - | 0.35 | 0.19 | 0.10 | 0.58 | 0.33 | 0.204 | 0.13 | 0.28 | 0.39 | 0.660 | 0.06 | 0.26 | 0.08 | 0.14 | ||
| PADL | 0–6 | - | 0.14 | 0.06 | 0.13 | 0.32 | 0.14 | 0.058 | 0.14 | 0.10 | 0.561 | 0.08 | 0.07 | 0.01 | 0.089 | 0.12 | ||
| IADL | 0–7 | - | 0.19 | 0.13 | 0.185 | 0.07 | 0.27 | 0.16 | 0.363 | 0.10 | 0.11 | 0.25 | 0.355 | 0.12 | 0.18 | 0.08 | 0.063 | 0.13 |
| GWI SF Score | 0–1 | + | -0.02 | -0.02 | 0.892 | 0.01 | -0.02 | -0.03 | 0.512 | 0.07 | -0.04 | 0.0 | 0.478 | 0.09 | -0.02 | -0.02 | 0.900 | 0.01 |
| QoL general | 0–5 | - | 0.08 | 0.10 | 0.636 | 0.02 | 0.17 | 0.14 | 0.587 | 0.06 | 0.12 | 0.09 | 0.818 | 0.03 | 0.03 | 0.08 | 0.289 | 0.07 |
| QoL vs 1 year ago | 0–5 | - | 0.08 | 0.04 | 0.320 | 0.05 | -0.04 | 0.01 | 0.471 | 0.08 | 0.11 | 0.17 | 0.425 | 0.10 | 0.13 | 0.02 | 0.16 | |
| SMAS-30 | 0–100 | + | -1.1 | -0.8 | 0.411 | 0.04 | -2.0 | 0.2 | -0.4 | -0.7 | 0.705 | 0.05 | -0.9 | -1.2 | 0.664 | 0.03 | ||
| INIT | 0–100 | + | -2.3 | -2.5 | 0.709 | 0.02 | -2.8 | -2.1 | 0.530 | 0.07 | -1.7 | -2.3 | 0.658 | 0.06 | -2.2 | -2.8 | 0.485 | 0.05 |
| SE | 0–100 | + | -0.8 | -0.9 | 0.455 | 0.04 | -2.1 | 1.7 | 0.0 | -1.3 | 0.619 | 0.07 | -0.4 | -2.0 | 0.585 | 0.04 | ||
| INVEST | 0–100 | + | -1.1 | 0.0 | 0.802 | 0.01 | -1.3 | 0.8 | -0.3 | 0.5 | 0.412 | 0.11 | -1.2 | -0.4 | 0.068 | 0.13 | ||
| POSITIVE | 0–100 | + | -0.2 | 0.2 | 0.542 | 0.03 | -0.2 | 1.2 | 0.217 | 0.13 | -0.3 | 0.5 | 0.680 | 0.05 | -0.1 | -0.3 | 0.835 | 0.01 |
| MULT | 0–100 | + | -0.8 | -0.4 | 0.124 | 0.08 | -1.9 | 1.1 | 0.126 | 0.16 | -1.1 | -1.7 | 0.609 | 0.07 | -0.2 | -0.6 | 0.383 | 0.06 |
| VAR | 0–100 | + | -1.3 | -0.8 | 0.461 | 0.04 | -3.2 | -1.3 | 0.177 | 0.14 | 1.2 | 0.3 | 0.450 | 0.10 | -1.2 | -0.8 | 0.649 | 0.03 |
| PIH-OA | 8–64 | + | 0.8 | 0.4 | 0.285 | 0.06 | 1.1 | 1.1 | 0.976 | 0.00 | 1.7 | -0.8 | 0.4 | 0.4 | 0.936 | 0.01 | ||
| Knowledge | 2–16 | + | 0.8 | 0.3 | 0.14 | 0.8 | 0.3 | 0.113 | 0.17 | 1.0 | -0.2 | 0.7 | 0.4 | 0.245 | 0.08 | |||
| Management | 2–16 | + | 0.1 | 0.0 | 0.691 | 0.02 | 0.2 | 0.2 | 0.969 | 0.00 | 0.2 | -0.2 | 0.398 | 0.11 | -0.1 | -0.1 | 0.965 | 0.00 |
| Coping | 4–32 | + | 0.0 | 0.1 | 0.659 | 0.02 | 0.1 | 0.6 | 0.336 | 0.10 | 0.6 | -0.4 | 0.119 | -0.2 | 0.0 | 0.355 | 0.06 | |
CAU = Care as usual; EQ-5D-3L = EuroQol-5D-3L; EQ-VAS = EuroQoL-5D visual analogue scale; ES = Effect size d, thresholds <0.2 trivial, ≥ 0.2–0.5 small, ≥0.5–0.8 medium, ≥ 0.8 large; GFI = Groningen Frailty Indicator; GWI SF Score = Groningen Well-being Indicator Satisfaction Score; IADL = Instrumental Activities of Daily Living; INIT = Taking initiatives subscale; INTERMED-E-SA = INTERMED for the Elderly Self-Assessment; INVEST = Investment behaviour subscale; MULT = Multi-functionality of resources subscale; PADL = Physical Activities of Daily Living; PIH-OA = Partners in Health scale for older adults; POSITIVE = Positive frame of mind subscale; QoL = Quality of life; SE = Self-efficacy beliefs subscale; SMAS-30 = Self-Management Ability Scale version 2; VAR = Variety in resources subscale.
* + Higher score means improvement;—higher score means deterioration.
† Values are corrected for age and sex; bold values indicate p<0.05.
1 Percentage of missing items at baseline before imputation 7.4%
2 Percentage of missing items at baseline before imputation 5.4% and 6.1% at follow-up.
3 Percentage of missing items at baseline before imputation 12.7%
4 Percentage of missing items at baseline before imputation 5.7%
Bold text and orange filling: Significant (p<0.05) or clinically relevant (ES ≥0.20) deterioration
Bold text and green filling: Significant (p<0.05) or clinically relevant (ES ≥0.20) improvement